SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Veloxis Pharmaceuticals A/S Completes Enrolment in LCP-Tacro(TM) 3002 Pivotal Phase III Trial in Kidney Transplant